FDA Drug Application (207793) for ONIVYDE by MERRIMACK PHARMS

Back to FDA Applications sponsored by MERRIMACK PHARMS

Application Number207793
Product Number001
FormINJECTABLE, LIPOSOMAL;IV (INFUSION)
DosageEQ 43MG BASE/10ML (EQ 4.3MG BASE/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameONIVYDE
Active IngredientIRINOTECAN HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient IRINOTECAN HYDROCHLORIDE3


Back to FDA Applications sponsored by MERRIMACK PHARMS